Global Omalizumab Biosimilars Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Omalizumab Biosimilars Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Omalizumab Biosimilars by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Omalizumab Biosimilars by Country/Region, 2017, 2022 & 2028

2.2 Omalizumab Biosimilars Segment by Type

2.2.1 150 mg/mL

2.2.2 75 mg/0.5 mL

2.3 Omalizumab Biosimilars Sales by Type

2.3.1 Global Omalizumab Biosimilars Sales Market Share by Type (2017-2022)

2.3.2 Global Omalizumab Biosimilars Revenue and Market Share by Type (2017-2022)

2.3.3 Global Omalizumab Biosimilars Sale Price by Type (2017-2022)

2.4 Omalizumab Biosimilars Segment by Application

2.4.1 Persistent Asthma

2.4.2 Nasal Polyps

2.4.3 Chronic Idiopathic Urticaria

2.5 Omalizumab Biosimilars Sales by Application

2.5.1 Global Omalizumab Biosimilars Sale Market Share by Application (2017-2022)

2.5.2 Global Omalizumab Biosimilars Revenue and Market Share by Application (2017-2022)

2.5.3 Global Omalizumab Biosimilars Sale Price by Application (2017-2022)

3 Global Omalizumab Biosimilars by Company

3.1 Global Omalizumab Biosimilars Breakdown Data by Company

3.1.1 Global Omalizumab Biosimilars Annual Sales by Company (2020-2022)

3.1.2 Global Omalizumab Biosimilars Sales Market Share by Company (2020-2022)

3.2 Global Omalizumab Biosimilars Annual Revenue by Company (2020-2022)

3.2.1 Global Omalizumab Biosimilars Revenue by Company (2020-2022)

3.2.2 Global Omalizumab Biosimilars Revenue Market Share by Company (2020-2022)

3.3 Global Omalizumab Biosimilars Sale Price by Company

3.4 Key Manufacturers Omalizumab Biosimilars Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Omalizumab Biosimilars Product Location Distribution

3.4.2 Players Omalizumab Biosimilars Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Omalizumab Biosimilars by Geographic Region

4.1 World Historic Omalizumab Biosimilars Market Size by Geographic Region (2017-2022)

4.1.1 Global Omalizumab Biosimilars Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Omalizumab Biosimilars Annual Revenue by Geographic Region

4.2 World Historic Omalizumab Biosimilars Market Size by Country/Region (2017-2022)

4.2.1 Global Omalizumab Biosimilars Annual Sales by Country/Region (2017-2022)

4.2.2 Global Omalizumab Biosimilars Annual Revenue by Country/Region

4.3 Americas Omalizumab Biosimilars Sales Growth

4.4 APAC Omalizumab Biosimilars Sales Growth

4.5 Europe Omalizumab Biosimilars Sales Growth

4.6 Middle East & Africa Omalizumab Biosimilars Sales Growth

5 Americas

5.1 Americas Omalizumab Biosimilars Sales by Country

5.1.1 Americas Omalizumab Biosimilars Sales by Country (2017-2022)

5.1.2 Americas Omalizumab Biosimilars Revenue by Country (2017-2022)

5.2 Americas Omalizumab Biosimilars Sales by Type

5.3 Americas Omalizumab Biosimilars Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Omalizumab Biosimilars Sales by Region

6.1.1 APAC Omalizumab Biosimilars Sales by Region (2017-2022)

6.1.2 APAC Omalizumab Biosimilars Revenue by Region (2017-2022)

6.2 APAC Omalizumab Biosimilars Sales by Type

6.3 APAC Omalizumab Biosimilars Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Omalizumab Biosimilars by Country

7.1.1 Europe Omalizumab Biosimilars Sales by Country (2017-2022)

7.1.2 Europe Omalizumab Biosimilars Revenue by Country (2017-2022)

7.2 Europe Omalizumab Biosimilars Sales by Type

7.3 Europe Omalizumab Biosimilars Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Omalizumab Biosimilars by Country

8.1.1 Middle East & Africa Omalizumab Biosimilars Sales by Country (2017-2022)

8.1.2 Middle East & Africa Omalizumab Biosimilars Revenue by Country (2017-2022)

8.2 Middle East & Africa Omalizumab Biosimilars Sales by Type

8.3 Middle East & Africa Omalizumab Biosimilars Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Omalizumab Biosimilars

10.3 Manufacturing Process Analysis of Omalizumab Biosimilars

10.4 Industry Chain Structure of Omalizumab Biosimilars

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Omalizumab Biosimilars Distributors

11.3 Omalizumab Biosimilars Customer

12 World Forecast Review for Omalizumab Biosimilars by Geographic Region

12.1 Global Omalizumab Biosimilars Market Size Forecast by Region

12.1.1 Global Omalizumab Biosimilars Forecast by Region (2023-2028)

12.1.2 Global Omalizumab Biosimilars Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Omalizumab Biosimilars Forecast by Type

12.7 Global Omalizumab Biosimilars Forecast by Application

13 Key Players Analysis

13.1 Roche

13.1.1 Roche Company Information

13.1.2 Roche Omalizumab Biosimilars Product Offered

13.1.3 Roche Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Roche Main Business Overview

13.1.5 Roche Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis Omalizumab Biosimilars Product Offered

13.2.3 Novartis Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Glenmark Pharmaceuticals

13.3.1 Glenmark Pharmaceuticals Company Information

13.3.2 Glenmark Pharmaceuticals Omalizumab Biosimilars Product Offered

13.3.3 Glenmark Pharmaceuticals Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Glenmark Pharmaceuticals Main Business Overview

13.3.5 Glenmark Pharmaceuticals Latest Developments

13.4 Selexis

13.4.1 Selexis Company Information

13.4.2 Selexis Omalizumab Biosimilars Product Offered

13.4.3 Selexis Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Selexis Main Business Overview

13.4.5 Selexis Latest Developments

13.5 Generium

13.5.1 Generium Company Information

13.5.2 Generium Omalizumab Biosimilars Product Offered

13.5.3 Generium Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Generium Main Business Overview

13.5.5 Generium Latest Developments

13.6 CuraTeQ

13.6.1 CuraTeQ Company Information

13.6.2 CuraTeQ Omalizumab Biosimilars Product Offered

13.6.3 CuraTeQ Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 CuraTeQ Main Business Overview

13.6.5 CuraTeQ Latest Developments

13.7 Celltrion Healthcare

13.7.1 Celltrion Healthcare Company Information

13.7.2 Celltrion Healthcare Omalizumab Biosimilars Product Offered

13.7.3 Celltrion Healthcare Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Celltrion Healthcare Main Business Overview

13.7.5 Celltrion Healthcare Latest Developments

13.8 Alvotech

13.8.1 Alvotech Company Information

13.8.2 Alvotech Omalizumab Biosimilars Product Offered

13.8.3 Alvotech Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Alvotech Main Business Overview

13.8.5 Alvotech Latest Developments

13.9 BiosanaPharma

13.9.1 BiosanaPharma Company Information

13.9.2 BiosanaPharma Omalizumab Biosimilars Product Offered

13.9.3 BiosanaPharma Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 BiosanaPharma Main Business Overview

13.9.5 BiosanaPharma Latest Developments

13.10 Mabpharm

13.10.1 Mabpharm Company Information

13.10.2 Mabpharm Omalizumab Biosimilars Product Offered

13.10.3 Mabpharm Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mabpharm Main Business Overview

13.10.5 Mabpharm Latest Developments

13.11 CSPC Pharmaceutical Group

13.11.1 CSPC Pharmaceutical Group Company Information

13.11.2 CSPC Pharmaceutical Group Omalizumab Biosimilars Product Offered

13.11.3 CSPC Pharmaceutical Group Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 CSPC Pharmaceutical Group Main Business Overview

13.11.5 CSPC Pharmaceutical Group Latest Developments

13.12 Biomabs

13.12.1 Biomabs Company Information

13.12.2 Biomabs Omalizumab Biosimilars Product Offered

13.12.3 Biomabs Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Biomabs Main Business Overview

13.12.5 Biomabs Latest Developments

13.13 HisunPharm

13.13.1 HisunPharm Company Information

13.13.2 HisunPharm Omalizumab Biosimilars Product Offered

13.13.3 HisunPharm Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 HisunPharm Main Business Overview

13.13.5 HisunPharm Latest Developments

13.14 Grand Pharm

13.14.1 Grand Pharm Company Information

13.14.2 Grand Pharm Omalizumab Biosimilars Product Offered

13.14.3 Grand Pharm Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Grand Pharm Main Business Overview

13.14.5 Grand Pharm Latest Developments

14 Research Findings and Conclusion

Table 1. Omalizumab Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Omalizumab Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 150 mg/mL

Table 4. Major Players of 75 mg/0.5 mL

Table 5. Global Omalizumab Biosimilars Sales by Type (2017-2022) & (Units)

Table 6. Global Omalizumab Biosimilars Sales Market Share by Type (2017-2022)

Table 7. Global Omalizumab Biosimilars Revenue by Type (2017-2022) & ($ million)

Table 8. Global Omalizumab Biosimilars Revenue Market Share by Type (2017-2022)

Table 9. Global Omalizumab Biosimilars Sale Price by Type (2017-2022) & (K USD/Unit)

Table 10. Global Omalizumab Biosimilars Sales by Application (2017-2022) & (Units)

Table 11. Global Omalizumab Biosimilars Sales Market Share by Application (2017-2022)

Table 12. Global Omalizumab Biosimilars Revenue by Application (2017-2022)

Table 13. Global Omalizumab Biosimilars Revenue Market Share by Application (2017-2022)

Table 14. Global Omalizumab Biosimilars Sale Price by Application (2017-2022) & (K USD/Unit)

Table 15. Global Omalizumab Biosimilars Sales by Company (2020-2022) & (Units)

Table 16. Global Omalizumab Biosimilars Sales Market Share by Company (2020-2022)

Table 17. Global Omalizumab Biosimilars Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Omalizumab Biosimilars Revenue Market Share by Company (2020-2022)

Table 19. Global Omalizumab Biosimilars Sale Price by Company (2020-2022) & (K USD/Unit)

Table 20. Key Manufacturers Omalizumab Biosimilars Producing Area Distribution and Sales Area

Table 21. Players Omalizumab Biosimilars Products Offered

Table 22. Omalizumab Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Omalizumab Biosimilars Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global Omalizumab Biosimilars Sales Market Share Geographic Region (2017-2022)

Table 27. Global Omalizumab Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Omalizumab Biosimilars Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Omalizumab Biosimilars Sales by Country/Region (2017-2022) & (Units)

Table 30. Global Omalizumab Biosimilars Sales Market Share by Country/Region (2017-2022)

Table 31. Global Omalizumab Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Omalizumab Biosimilars Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Omalizumab Biosimilars Sales by Country (2017-2022) & (Units)

Table 34. Americas Omalizumab Biosimilars Sales Market Share by Country (2017-2022)

Table 35. Americas Omalizumab Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Omalizumab Biosimilars Revenue Market Share by Country (2017-2022)

Table 37. Americas Omalizumab Biosimilars Sales by Type (2017-2022) & (Units)

Table 38. Americas Omalizumab Biosimilars Sales Market Share by Type (2017-2022)

Table 39. Americas Omalizumab Biosimilars Sales by Application (2017-2022) & (Units)

Table 40. Americas Omalizumab Biosimilars Sales Market Share by Application (2017-2022)

Table 41. APAC Omalizumab Biosimilars Sales by Region (2017-2022) & (Units)

Table 42. APAC Omalizumab Biosimilars Sales Market Share by Region (2017-2022)

Table 43. APAC Omalizumab Biosimilars Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Omalizumab Biosimilars Revenue Market Share by Region (2017-2022)

Table 45. APAC Omalizumab Biosimilars Sales by Type (2017-2022) & (Units)

Table 46. APAC Omalizumab Biosimilars Sales Market Share by Type (2017-2022)

Table 47. APAC Omalizumab Biosimilars Sales by Application (2017-2022) & (Units)

Table 48. APAC Omalizumab Biosimilars Sales Market Share by Application (2017-2022)

Table 49. Europe Omalizumab Biosimilars Sales by Country (2017-2022) & (Units)

Table 50. Europe Omalizumab Biosimilars Sales Market Share by Country (2017-2022)

Table 51. Europe Omalizumab Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Omalizumab Biosimilars Revenue Market Share by Country (2017-2022)

Table 53. Europe Omalizumab Biosimilars Sales by Type (2017-2022) & (Units)

Table 54. Europe Omalizumab Biosimilars Sales Market Share by Type (2017-2022)

Table 55. Europe Omalizumab Biosimilars Sales by Application (2017-2022) & (Units)

Table 56. Europe Omalizumab Biosimilars Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Omalizumab Biosimilars Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa Omalizumab Biosimilars Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Omalizumab Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Omalizumab Biosimilars Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Omalizumab Biosimilars Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa Omalizumab Biosimilars Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Omalizumab Biosimilars Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa Omalizumab Biosimilars Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Omalizumab Biosimilars

Table 66. Key Market Challenges & Risks of Omalizumab Biosimilars

Table 67. Key Industry Trends of Omalizumab Biosimilars

Table 68. Omalizumab Biosimilars Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Omalizumab Biosimilars Distributors List

Table 71. Omalizumab Biosimilars Customer List

Table 72. Global Omalizumab Biosimilars Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global Omalizumab Biosimilars Sales Market Forecast by Region

Table 74. Global Omalizumab Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Omalizumab Biosimilars Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Omalizumab Biosimilars Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas Omalizumab Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Omalizumab Biosimilars Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC Omalizumab Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Omalizumab Biosimilars Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe Omalizumab Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Omalizumab Biosimilars Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa Omalizumab Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Omalizumab Biosimilars Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global Omalizumab Biosimilars Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Omalizumab Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Omalizumab Biosimilars Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Omalizumab Biosimilars Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global Omalizumab Biosimilars Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Omalizumab Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Omalizumab Biosimilars Revenue Market Share Forecast by Application (2023-2028)

Table 92. Roche Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 93. Roche Omalizumab Biosimilars Product Offered

Table 94. Roche Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 95. Roche Main Business

Table 96. Roche Latest Developments

Table 97. Novartis Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 98. Novartis Omalizumab Biosimilars Product Offered

Table 99. Novartis Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 100. Novartis Main Business

Table 101. Novartis Latest Developments

Table 102. Glenmark Pharmaceuticals Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 103. Glenmark Pharmaceuticals Omalizumab Biosimilars Product Offered

Table 104. Glenmark Pharmaceuticals Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 105. Glenmark Pharmaceuticals Main Business

Table 106. Glenmark Pharmaceuticals Latest Developments

Table 107. Selexis Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 108. Selexis Omalizumab Biosimilars Product Offered

Table 109. Selexis Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 110. Selexis Main Business

Table 111. Selexis Latest Developments

Table 112. Generium Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 113. Generium Omalizumab Biosimilars Product Offered

Table 114. Generium Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 115. Generium Main Business

Table 116. Generium Latest Developments

Table 117. CuraTeQ Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 118. CuraTeQ Omalizumab Biosimilars Product Offered

Table 119. CuraTeQ Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 120. CuraTeQ Main Business

Table 121. CuraTeQ Latest Developments

Table 122. Celltrion Healthcare Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 123. Celltrion Healthcare Omalizumab Biosimilars Product Offered

Table 124. Celltrion Healthcare Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 125. Celltrion Healthcare Main Business

Table 126. Celltrion Healthcare Latest Developments

Table 127. Alvotech Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 128. Alvotech Omalizumab Biosimilars Product Offered

Table 129. Alvotech Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 130. Alvotech Main Business

Table 131. Alvotech Latest Developments

Table 132. BiosanaPharma Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 133. BiosanaPharma Omalizumab Biosimilars Product Offered

Table 134. BiosanaPharma Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 135. BiosanaPharma Main Business

Table 136. BiosanaPharma Latest Developments

Table 137. Mabpharm Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 138. Mabpharm Omalizumab Biosimilars Product Offered

Table 139. Mabpharm Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 140. Mabpharm Main Business

Table 141. Mabpharm Latest Developments

Table 142. CSPC Pharmaceutical Group Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 143. CSPC Pharmaceutical Group Omalizumab Biosimilars Product Offered

Table 144. CSPC Pharmaceutical Group Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 145. CSPC Pharmaceutical Group Main Business

Table 146. CSPC Pharmaceutical Group Latest Developments

Table 147. Biomabs Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 148. Biomabs Omalizumab Biosimilars Product Offered

Table 149. Biomabs Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 150. Biomabs Main Business

Table 151. Biomabs Latest Developments

Table 152. HisunPharm Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 153. HisunPharm Omalizumab Biosimilars Product Offered

Table 154. HisunPharm Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 155. HisunPharm Main Business

Table 156. HisunPharm Latest Developments

Table 157. Grand Pharm Basic Information, Omalizumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 158. Grand Pharm Omalizumab Biosimilars Product Offered

Table 159. Grand Pharm Omalizumab Biosimilars Sales (Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 160. Grand Pharm Main Business

Table 161. Grand Pharm Latest Developments

List of Figures

Figure 1. Picture of Omalizumab Biosimilars

Figure 2. Omalizumab Biosimilars Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Omalizumab Biosimilars Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Omalizumab Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Omalizumab Biosimilars Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 150 mg/mL

Figure 10. Product Picture of 75 mg/0.5 mL

Figure 11. Global Omalizumab Biosimilars Sales Market Share by Type in 2021

Figure 12. Global Omalizumab Biosimilars Revenue Market Share by Type (2017-2022)

Figure 13. Omalizumab Biosimilars Consumed in Persistent Asthma

Figure 14. Global Omalizumab Biosimilars Market: Persistent Asthma (2017-2022) & (Units)

Figure 15. Omalizumab Biosimilars Consumed in Nasal Polyps

Figure 16. Global Omalizumab Biosimilars Market: Nasal Polyps (2017-2022) & (Units)

Figure 17. Omalizumab Biosimilars Consumed in Chronic Idiopathic Urticaria

Figure 18. Global Omalizumab Biosimilars Market: Chronic Idiopathic Urticaria (2017-2022) & (Units)

Figure 19. Global Omalizumab Biosimilars Sales Market Share by Application (2017-2022)

Figure 20. Global Omalizumab Biosimilars Revenue Market Share by Application in 2021

Figure 21. Omalizumab Biosimilars Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Omalizumab Biosimilars Revenue Market Share by Company in 2021

Figure 23. Global Omalizumab Biosimilars Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Omalizumab Biosimilars Revenue Market Share by Geographic Region in 2021

Figure 25. Global Omalizumab Biosimilars Sales Market Share by Region (2017-2022)

Figure 26. Global Omalizumab Biosimilars Revenue Market Share by Country/Region in 2021

Figure 27. Americas Omalizumab Biosimilars Sales 2017-2022 (Units)

Figure 28. Americas Omalizumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 29. APAC Omalizumab Biosimilars Sales 2017-2022 (Units)

Figure 30. APAC Omalizumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 31. Europe Omalizumab Biosimilars Sales 2017-2022 (Units)

Figure 32. Europe Omalizumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Omalizumab Biosimilars Sales 2017-2022 (Units)

Figure 34. Middle East & Africa Omalizumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 35. Americas Omalizumab Biosimilars Sales Market Share by Country in 2021

Figure 36. Americas Omalizumab Biosimilars Revenue Market Share by Country in 2021

Figure 37. United States Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Omalizumab Biosimilars Sales Market Share by Region in 2021

Figure 42. APAC Omalizumab Biosimilars Revenue Market Share by Regions in 2021

Figure 43. China Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Omalizumab Biosimilars Sales Market Share by Country in 2021

Figure 50. Europe Omalizumab Biosimilars Revenue Market Share by Country in 2021

Figure 51. Germany Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Omalizumab Biosimilars Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Omalizumab Biosimilars Revenue Market Share by Country in 2021

Figure 58. Egypt Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Omalizumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Omalizumab Biosimilars in 2021

Figure 64. Manufacturing Process Analysis of Omalizumab Biosimilars

Figure 65. Industry Chain Structure of Omalizumab Biosimilars

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles